首页|药品上市许可持有人对受托企业生产现场全过程监督存在问题的分析及建议

药品上市许可持有人对受托企业生产现场全过程监督存在问题的分析及建议

扫码查看
目的:探索在新形势下药品上市许可持有人(MAH)对受托企业生产现场全过程监督的应对策略.方法:通过梳理广东省药品B类生产许可证(以下简称B证)持有人委托省外企业生产的延伸检查情况,深入探讨当前MAH在受托企业生产现场全过程监督中存在的问题及原因,并根据药品生产质量管理和关于加强上市后持有人管理的相关规定提出了相应的改进建议.结果:对受托生产延伸检查状况进行整理,发现MAH在关键人员配置、全过程监督理解、生产风险研判3个方面存在问题,具体表现为人员工作经验不丰富、全过程监督方式不严谨、生产风险研判不全面.结论:建议B证持有人聚焦关键人员压实主体责任、完善管理流程规范监督行为、强化风险研判排查安全隐患,确保关键人员的数量资质与生产规模匹配、形成全过程生产的闭环质量管理、开展全方位精准化风险研判,牢固树立药品质量安全意识.
Analysis and Suggestions on the Problems Regarding the Full Process Production Site Supervision of the Entrusted Enterprise by Marketing Authorization Holder
Objective:To explore the coping strategy to the full process production site supervision of the entrusted enterprise by Marketing Authorization Holder(MAH)under the new situations.Methods:By combing the extension inspectd of entrusted production enterprises outside the province by pharmaceutical contract manufacture(hereinafter referred to as the B-certificate)MAH in Guangdong Province,the problems and reasons for the full process production site supervision of the entrusted enterprise were deeply discussed,and the corresponding improvement suggestions were put forward,according to the quality management of drug production and the relevant provisions on strengthening the management of holders after listing.Results:After combing the status of entrusted production extension inspections,it was found that three aspects problems of holders about key personnel configuration,understanding of the entire process supervision and production risk assessment,which were manifested in the lack of rich work experience of personnel,the lack of rigorous supervision methods throughout the entire process,and the incomplete assessment of production risks.Conclusion:The B-certificate MAH should focus on key personnel to fulfill their main responsibilities,improve management processes to standardize supervision behavior,strengthen risk assessment to identify safety hazards,so as to ensure the number and qualifications of key personnel match the production scale,form a closed-loop quality management system for the entire production process,carry out comprehensive and precise risk assessment,and firmly establish awareness of drug quality and safety.

marketing authorization holderentrusted enterprisethe full process production site supervisionmain issuesanalysis suggestions

许广宁、邓雯姬、张庆芬、庞精聪、李书聪

展开 >

广东省药品监督管理局审评认证中心,广州 510080

药品上市许可持有人 受托企业 全过程生产监督 主要问题 分析建议

2024

中国药事
中国食品药品检定研究院(中国药品生物制品检定所)

中国药事

CSTPCD
影响因子:0.844
ISSN:1002-7777
年,卷(期):2024.38(10)